 Amanda Law
Concepts (321)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Schizophrenia | 33 | 2019 | 433 | 7.030 |
Why?
| | Neuregulin-1 | 17 | 2020 | 46 | 3.560 |
Why?
| | Prefrontal Cortex | 13 | 2020 | 293 | 2.850 |
Why?
| | Neuregulins | 5 | 2020 | 7 | 2.500 |
Why?
| | Hippocampus | 17 | 2020 | 785 | 2.030 |
Why?
| | ErbB Receptors | 8 | 2020 | 601 | 1.800 |
Why?
| | Nerve Tissue Proteins | 10 | 2015 | 568 | 1.680 |
Why?
| | Alternative Splicing | 6 | 2020 | 215 | 1.500 |
Why?
| | Brain | 15 | 2021 | 2592 | 1.490 |
Why?
| | Proto-Oncogene Proteins c-akt | 5 | 2020 | 418 | 1.390 |
Why?
| | Choline | 9 | 2022 | 117 | 1.250 |
Why?
| | Bipolar Disorder | 5 | 2016 | 232 | 1.210 |
Why?
| | TOR Serine-Threonine Kinases | 3 | 2020 | 379 | 1.170 |
Why?
| | Behavior, Animal | 4 | 2020 | 482 | 1.050 |
Why?
| | Protein Isoforms | 10 | 2018 | 369 | 1.020 |
Why?
| | Gene Expression Regulation, Developmental | 7 | 2020 | 816 | 0.990 |
Why?
| | Prenatal Exposure Delayed Effects | 7 | 2021 | 544 | 0.990 |
Why?
| | Cell Adhesion Molecules, Neuronal | 3 | 2015 | 39 | 0.940 |
Why?
| | Genetic Predisposition to Disease | 10 | 2019 | 2270 | 0.910 |
Why?
| | Antipsychotic Agents | 6 | 2016 | 194 | 0.880 |
Why?
| | Gene Expression | 9 | 2018 | 1476 | 0.870 |
Why?
| | MicroRNAs | 2 | 2019 | 668 | 0.820 |
Why?
| | Receptor, ErbB-4 | 9 | 2020 | 18 | 0.820 |
Why?
| | Phosphatidylinositol 3-Kinases | 3 | 2020 | 359 | 0.810 |
Why?
| | RNA, Messenger | 16 | 2020 | 2700 | 0.800 |
Why?
| | Class I Phosphatidylinositol 3-Kinases | 2 | 2019 | 81 | 0.740 |
Why?
| | Fetus | 8 | 2021 | 764 | 0.740 |
Why?
| | Polymorphism, Single Nucleotide | 9 | 2014 | 2070 | 0.720 |
Why?
| | Brain Chemistry | 4 | 2009 | 115 | 0.720 |
Why?
| | Maternal Deprivation | 3 | 2010 | 16 | 0.700 |
Why?
| | Aging | 4 | 2020 | 1767 | 0.700 |
Why?
| | Fetal Development | 7 | 2021 | 283 | 0.670 |
Why?
| | C-Reactive Protein | 4 | 2022 | 394 | 0.670 |
Why?
| | Sensory Gating | 2 | 2019 | 42 | 0.670 |
Why?
| | Minisatellite Repeats | 1 | 2019 | 40 | 0.650 |
Why?
| | Signal Transduction | 9 | 2018 | 4857 | 0.620 |
Why?
| | Genotype | 8 | 2016 | 1834 | 0.600 |
Why?
| | Depressive Disorder, Major | 3 | 2016 | 347 | 0.590 |
Why?
| | Cloning, Molecular | 2 | 2010 | 536 | 0.580 |
Why?
| | gamma-Aminobutyric Acid | 3 | 2018 | 154 | 0.570 |
Why?
| | Gene Expression Regulation | 5 | 2019 | 2520 | 0.560 |
Why?
| | Interleukin-1beta | 1 | 2019 | 376 | 0.560 |
Why?
| | Glutamic Acid | 2 | 2018 | 227 | 0.560 |
Why?
| | Cerebral Cortex | 3 | 2011 | 407 | 0.550 |
Why?
| | Receptors, N-Methyl-D-Aspartate | 3 | 2003 | 205 | 0.540 |
Why?
| | Neurophysiology | 1 | 2016 | 11 | 0.530 |
Why?
| | Memory Disorders | 1 | 2017 | 156 | 0.510 |
Why?
| | Multiprotein Complexes | 1 | 2017 | 147 | 0.510 |
Why?
| | Microfilament Proteins | 3 | 2008 | 130 | 0.500 |
Why?
| | Mood Disorders | 2 | 2008 | 120 | 0.500 |
Why?
| | Microtubule-Associated Proteins | 3 | 2008 | 182 | 0.490 |
Why?
| | Neocortex | 1 | 2015 | 32 | 0.480 |
Why?
| | Tumor Necrosis Factor-alpha | 1 | 2019 | 1204 | 0.450 |
Why?
| | Psychomotor Performance | 2 | 2014 | 310 | 0.450 |
Why?
| | Gestational Age | 5 | 2022 | 857 | 0.440 |
Why?
| | Adult | 29 | 2022 | 35361 | 0.440 |
Why?
| | Epidermal Growth Factor | 1 | 2014 | 170 | 0.440 |
Why?
| | Neurogenesis | 1 | 2014 | 115 | 0.420 |
Why?
| | Pregnancy Complications, Infectious | 3 | 2021 | 334 | 0.390 |
Why?
| | Alleles | 3 | 2011 | 847 | 0.390 |
Why?
| | Promoter Regions, Genetic | 4 | 2019 | 1194 | 0.380 |
Why?
| | Female | 36 | 2022 | 68162 | 0.370 |
Why?
| | Male | 32 | 2022 | 63146 | 0.350 |
Why?
| | Quinazolines | 1 | 2012 | 245 | 0.350 |
Why?
| | Inflammation | 3 | 2021 | 2694 | 0.350 |
Why?
| | Heterozygote | 1 | 2011 | 268 | 0.350 |
Why?
| | Humans | 49 | 2022 | 128896 | 0.350 |
Why?
| | Adenine | 1 | 2012 | 247 | 0.340 |
Why?
| | Pregnancy | 13 | 2022 | 6247 | 0.340 |
Why?
| | Infant Behavior | 2 | 2020 | 25 | 0.340 |
Why?
| | Infant, Newborn | 11 | 2022 | 5704 | 0.320 |
Why?
| | Pyramidal Cells | 3 | 2004 | 70 | 0.320 |
Why?
| | Phenotype | 2 | 2014 | 3059 | 0.320 |
Why?
| | Peptides | 1 | 2014 | 902 | 0.310 |
Why?
| | Paternal Deprivation | 1 | 2008 | 4 | 0.310 |
Why?
| | Gyrus Cinguli | 1 | 2008 | 78 | 0.310 |
Why?
| | Animals | 17 | 2021 | 34628 | 0.290 |
Why?
| | Genome-Wide Association Study | 5 | 2019 | 1334 | 0.290 |
Why?
| | Case-Control Studies | 7 | 2019 | 3334 | 0.280 |
Why?
| | Middle Aged | 18 | 2019 | 30977 | 0.280 |
Why?
| | Young Adult | 11 | 2022 | 12286 | 0.280 |
Why?
| | Amygdala | 1 | 2008 | 182 | 0.280 |
Why?
| | Disease Models, Animal | 3 | 2016 | 3994 | 0.270 |
Why?
| | Cyclophilins | 2 | 2004 | 34 | 0.270 |
Why?
| | Memory, Short-Term | 3 | 2018 | 255 | 0.270 |
Why?
| | Mice | 8 | 2020 | 16543 | 0.270 |
Why?
| | Neuronal Plasticity | 2 | 2008 | 256 | 0.260 |
Why?
| | Blotting, Western | 3 | 2016 | 1188 | 0.260 |
Why?
| | Neurobiology | 1 | 2006 | 16 | 0.260 |
Why?
| | Infant | 10 | 2021 | 8994 | 0.250 |
Why?
| | Pregnancy Complications | 2 | 2021 | 487 | 0.250 |
Why?
| | Psychotic Disorders | 2 | 2021 | 152 | 0.250 |
Why?
| | Cohort Studies | 8 | 2016 | 5394 | 0.240 |
Why?
| | Neural Cell Adhesion Molecules | 2 | 2015 | 28 | 0.240 |
Why?
| | Protein Structure, Tertiary | 1 | 2006 | 832 | 0.230 |
Why?
| | Depression | 3 | 2021 | 1289 | 0.230 |
Why?
| | Neurites | 1 | 2004 | 45 | 0.220 |
Why?
| | Adolescent | 11 | 2019 | 20197 | 0.220 |
Why?
| | Real-Time Polymerase Chain Reaction | 2 | 2016 | 326 | 0.220 |
Why?
| | Antibodies, Anti-Idiotypic | 1 | 2003 | 56 | 0.220 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 3 | 2012 | 957 | 0.220 |
Why?
| | Memory | 2 | 2016 | 231 | 0.220 |
Why?
| | Dendrites | 1 | 2004 | 100 | 0.220 |
Why?
| | Neurofilament Proteins | 1 | 2003 | 44 | 0.210 |
Why?
| | Hydrocortisone | 2 | 2020 | 300 | 0.210 |
Why?
| | Calcium-Binding Proteins | 2 | 2015 | 213 | 0.210 |
Why?
| | Folic Acid | 2 | 2021 | 182 | 0.210 |
Why?
| | Synapses | 3 | 2004 | 379 | 0.200 |
Why?
| | Aged | 10 | 2019 | 22035 | 0.200 |
Why?
| | Infant, Small for Gestational Age | 1 | 2022 | 83 | 0.200 |
Why?
| | Heart Rate, Fetal | 1 | 2021 | 20 | 0.190 |
Why?
| | Child Development | 3 | 2021 | 451 | 0.190 |
Why?
| | In Situ Hybridization | 4 | 2010 | 295 | 0.180 |
Why?
| | Risk | 2 | 2014 | 866 | 0.180 |
Why?
| | Up-Regulation | 3 | 2019 | 848 | 0.180 |
Why?
| | Child, Preschool | 9 | 2021 | 10457 | 0.180 |
Why?
| | Callithrix | 3 | 2010 | 11 | 0.180 |
Why?
| | Molecular Sequence Data | 3 | 2010 | 2842 | 0.180 |
Why?
| | Child | 11 | 2021 | 20824 | 0.170 |
Why?
| | Mothers | 3 | 2021 | 723 | 0.170 |
Why?
| | Down-Regulation | 2 | 2007 | 637 | 0.170 |
Why?
| | Receptor, ErbB-3 | 1 | 2020 | 45 | 0.170 |
Why?
| | Nerve Growth Factors | 1 | 2020 | 73 | 0.170 |
Why?
| | 5' Untranslated Regions | 1 | 2019 | 54 | 0.160 |
Why?
| | Animals, Newborn | 2 | 2014 | 813 | 0.160 |
Why?
| | Aged, 80 and over | 4 | 2016 | 7050 | 0.160 |
Why?
| | HEK293 Cells | 2 | 2019 | 673 | 0.160 |
Why?
| | Risk Factors | 6 | 2019 | 9792 | 0.160 |
Why?
| | Hallucinogens | 1 | 2021 | 87 | 0.160 |
Why?
| | Haplotypes | 4 | 2013 | 473 | 0.160 |
Why?
| | Organ Specificity | 1 | 2019 | 296 | 0.160 |
Why?
| | Neurons | 3 | 2019 | 1425 | 0.150 |
Why?
| | Nutritional Status | 1 | 2021 | 325 | 0.150 |
Why?
| | Analysis of Variance | 3 | 2012 | 1283 | 0.150 |
Why?
| | Adrenal Cortex Hormones | 1 | 2021 | 525 | 0.150 |
Why?
| | Mice, Transgenic | 4 | 2018 | 2073 | 0.150 |
Why?
| | RNA, Long Noncoding | 1 | 2020 | 175 | 0.140 |
Why?
| | Age of Onset | 1 | 2019 | 494 | 0.140 |
Why?
| | Receptor, ErbB-2 | 1 | 2020 | 333 | 0.140 |
Why?
| | Exons | 2 | 2010 | 330 | 0.140 |
Why?
| | Cell Lineage | 1 | 2019 | 333 | 0.140 |
Why?
| | Psychiatric Status Rating Scales | 3 | 2014 | 525 | 0.140 |
Why?
| | alpha7 Nicotinic Acetylcholine Receptor | 2 | 2015 | 100 | 0.140 |
Why?
| | Maternal Exposure | 1 | 2019 | 173 | 0.140 |
Why?
| | Solute Carrier Family 12, Member 2 | 2 | 2014 | 7 | 0.140 |
Why?
| | Betacoronavirus | 1 | 2020 | 266 | 0.140 |
Why?
| | Autopsy | 2 | 2014 | 89 | 0.140 |
Why?
| | Mechanistic Target of Rapamycin Complex 2 | 1 | 2017 | 59 | 0.140 |
Why?
| | Genetic Markers | 2 | 2010 | 335 | 0.140 |
Why?
| | Placenta | 2 | 2021 | 706 | 0.130 |
Why?
| | Reflex, Startle | 2 | 2014 | 61 | 0.130 |
Why?
| | Conditioning, Classical | 1 | 2017 | 97 | 0.130 |
Why?
| | Locomotion | 1 | 2017 | 98 | 0.130 |
Why?
| | Rats, Sprague-Dawley | 3 | 2012 | 2308 | 0.120 |
Why?
| | Immunohistochemistry | 3 | 2004 | 1694 | 0.120 |
Why?
| | Phosphatidylcholines | 1 | 2015 | 146 | 0.120 |
Why?
| | Tissue Distribution | 2 | 2006 | 295 | 0.120 |
Why?
| | Fear | 1 | 2017 | 317 | 0.110 |
Why?
| | Genotyping Techniques | 1 | 2014 | 72 | 0.110 |
Why?
| | Cannabis | 1 | 2021 | 438 | 0.110 |
Why?
| | Catechol O-Methyltransferase | 1 | 2013 | 18 | 0.110 |
Why?
| | DiGeorge Syndrome | 1 | 2013 | 30 | 0.110 |
Why?
| | Polymorphism, Genetic | 1 | 2016 | 641 | 0.110 |
Why?
| | Child Behavior | 1 | 2015 | 235 | 0.110 |
Why?
| | Blood-Brain Barrier | 1 | 2014 | 128 | 0.110 |
Why?
| | Transcription, Genetic | 1 | 2019 | 1408 | 0.100 |
Why?
| | Double-Blind Method | 2 | 2015 | 1858 | 0.100 |
Why?
| | Photic Stimulation | 1 | 2014 | 238 | 0.100 |
Why?
| | Mental Disorders | 1 | 2021 | 1024 | 0.100 |
Why?
| | Pharmacogenetics | 1 | 2014 | 170 | 0.100 |
Why?
| | Amphetamine | 1 | 2012 | 24 | 0.100 |
Why?
| | Dietary Supplements | 3 | 2021 | 533 | 0.100 |
Why?
| | Rats | 3 | 2012 | 5236 | 0.100 |
Why?
| | Cell Line, Transformed | 1 | 2012 | 140 | 0.100 |
Why?
| | Cross-Over Studies | 1 | 2014 | 513 | 0.090 |
Why?
| | Cerebellum | 2 | 2004 | 216 | 0.090 |
Why?
| | Biological Clocks | 1 | 2011 | 40 | 0.090 |
Why?
| | Mice, Inbred C57BL | 3 | 2018 | 5270 | 0.090 |
Why?
| | Neuropsychiatry | 1 | 2011 | 17 | 0.090 |
Why?
| | Molecular Structure | 1 | 2012 | 469 | 0.090 |
Why?
| | Synaptophysin | 2 | 2008 | 14 | 0.090 |
Why?
| | Drug Discovery | 1 | 2011 | 130 | 0.090 |
Why?
| | Genetic Association Studies | 1 | 2012 | 356 | 0.090 |
Why?
| | Epistasis, Genetic | 1 | 2010 | 69 | 0.090 |
Why?
| | Receptors, Mineralocorticoid | 1 | 2010 | 9 | 0.090 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2014 | 1968 | 0.080 |
Why?
| | Adenosine | 1 | 2011 | 213 | 0.080 |
Why?
| | Oxygen | 2 | 2014 | 912 | 0.080 |
Why?
| | Motor Activity | 1 | 2014 | 666 | 0.080 |
Why?
| | Family | 1 | 2014 | 650 | 0.080 |
Why?
| | Long-Term Potentiation | 1 | 2011 | 180 | 0.080 |
Why?
| | Social Isolation | 1 | 2010 | 61 | 0.080 |
Why?
| | Family Health | 1 | 2010 | 199 | 0.080 |
Why?
| | Schizophrenic Psychology | 1 | 2009 | 93 | 0.080 |
Why?
| | Gene Frequency | 1 | 2010 | 503 | 0.080 |
Why?
| | Tritium | 1 | 2008 | 74 | 0.080 |
Why?
| | Receptors, Serotonin | 1 | 2008 | 32 | 0.080 |
Why?
| | Vesicular Glutamate Transport Protein 1 | 1 | 2008 | 2 | 0.080 |
Why?
| | GAP-43 Protein | 1 | 2008 | 5 | 0.080 |
Why?
| | Vesicular Inhibitory Amino Acid Transport Proteins | 1 | 2008 | 4 | 0.080 |
Why?
| | Receptors, Glucocorticoid | 1 | 2010 | 145 | 0.080 |
Why?
| | Flow Cytometry | 1 | 2012 | 1146 | 0.080 |
Why?
| | Receptor, Serotonin, 5-HT1A | 1 | 2008 | 38 | 0.070 |
Why?
| | Action Potentials | 1 | 2011 | 463 | 0.070 |
Why?
| | Prenatal Care | 2 | 2021 | 272 | 0.070 |
Why?
| | Genetic Variation | 3 | 2011 | 935 | 0.070 |
Why?
| | Phosphorylation | 1 | 2012 | 1685 | 0.070 |
Why?
| | Brain-Derived Neurotrophic Factor | 1 | 2008 | 110 | 0.070 |
Why?
| | Vitamin D | 2 | 2021 | 384 | 0.070 |
Why?
| | Gene Components | 1 | 2006 | 5 | 0.070 |
Why?
| | B-Lymphocytes | 1 | 2012 | 813 | 0.070 |
Why?
| | Base Sequence | 1 | 2010 | 2157 | 0.070 |
Why?
| | Amino Acid Sequence | 1 | 2010 | 2047 | 0.070 |
Why?
| | Piperazines | 1 | 2008 | 326 | 0.070 |
Why?
| | Synaptic Transmission | 1 | 2008 | 258 | 0.060 |
Why?
| | Logistic Models | 3 | 2022 | 1963 | 0.060 |
Why?
| | Membrane Proteins | 2 | 2010 | 1100 | 0.060 |
Why?
| | Image Processing, Computer-Assisted | 1 | 2010 | 739 | 0.060 |
Why?
| | Reward | 1 | 2008 | 238 | 0.060 |
Why?
| | Pyridines | 1 | 2008 | 472 | 0.060 |
Why?
| | Receptors, Nicotinic | 1 | 2007 | 323 | 0.060 |
Why?
| | Autoradiography | 1 | 2004 | 76 | 0.060 |
Why?
| | Histocytochemistry | 1 | 2004 | 78 | 0.060 |
Why?
| | Chlorpromazine | 1 | 2004 | 5 | 0.060 |
Why?
| | Clozapine | 1 | 2004 | 20 | 0.060 |
Why?
| | Risperidone | 1 | 2004 | 27 | 0.060 |
Why?
| | Functional Laterality | 2 | 2003 | 216 | 0.060 |
Why?
| | Haloperidol | 1 | 2004 | 36 | 0.060 |
Why?
| | Amino Acid Transport System X-AG | 1 | 2003 | 2 | 0.060 |
Why?
| | Nerve Fibers, Myelinated | 1 | 2004 | 42 | 0.060 |
Why?
| | Receptors, Glutamate | 1 | 2003 | 22 | 0.060 |
Why?
| | Oligonucleotide Probes | 1 | 2003 | 54 | 0.050 |
Why?
| | Receptors, Growth Factor | 1 | 2003 | 55 | 0.050 |
Why?
| | Presynaptic Terminals | 1 | 2004 | 64 | 0.050 |
Why?
| | Semaphorin-3A | 1 | 2003 | 2 | 0.050 |
Why?
| | Brain Stem | 1 | 2004 | 95 | 0.050 |
Why?
| | Purkinje Cells | 1 | 2004 | 67 | 0.050 |
Why?
| | Benzodiazepines | 1 | 2004 | 132 | 0.050 |
Why?
| | Cell Count | 1 | 2003 | 316 | 0.050 |
Why?
| | Postmortem Changes | 2 | 2014 | 16 | 0.050 |
Why?
| | Fluorescent Antibody Technique | 1 | 2003 | 392 | 0.050 |
Why?
| | Binding Sites | 1 | 2006 | 1238 | 0.050 |
Why?
| | Protein Binding | 1 | 2008 | 2086 | 0.050 |
Why?
| | Absorptiometry, Photon | 1 | 2003 | 249 | 0.050 |
Why?
| | Pandemics | 2 | 2021 | 1516 | 0.050 |
Why?
| | Wechsler Scales | 1 | 2021 | 53 | 0.050 |
Why?
| | Pregnancy Trimester, Third | 1 | 2021 | 105 | 0.050 |
Why?
| | Social Problems | 1 | 2021 | 12 | 0.050 |
Why?
| | Vitamin A | 1 | 2021 | 55 | 0.050 |
Why?
| | Nutritional Requirements | 1 | 2021 | 76 | 0.040 |
Why?
| | Nerve Net | 1 | 2003 | 249 | 0.040 |
Why?
| | Intelligence | 1 | 2021 | 128 | 0.040 |
Why?
| | Micronutrients | 1 | 2021 | 84 | 0.040 |
Why?
| | Nootropic Agents | 1 | 2020 | 28 | 0.040 |
Why?
| | Object Attachment | 1 | 2020 | 41 | 0.040 |
Why?
| | Vitamins | 1 | 2021 | 171 | 0.040 |
Why?
| | Fatty Acids, Omega-3 | 1 | 2021 | 138 | 0.040 |
Why?
| | Feasibility Studies | 1 | 2003 | 859 | 0.040 |
Why?
| | Treatment Outcome | 1 | 2014 | 10239 | 0.040 |
Why?
| | Pituitary-Adrenal System | 1 | 2020 | 142 | 0.040 |
Why?
| | Hypothalamo-Hypophyseal System | 1 | 2020 | 176 | 0.040 |
Why?
| | Maternal Age | 1 | 2019 | 121 | 0.040 |
Why?
| | Magnetic Resonance Imaging | 1 | 2010 | 3348 | 0.040 |
Why?
| | Reference Values | 2 | 2010 | 791 | 0.040 |
Why?
| | Developmental Disabilities | 1 | 2021 | 254 | 0.040 |
Why?
| | Transcription Factors | 1 | 2006 | 1634 | 0.040 |
Why?
| | Stress, Psychological | 2 | 2020 | 1051 | 0.040 |
Why?
| | Urinary Tract Infections | 1 | 2019 | 144 | 0.030 |
Why?
| | Encephalitis | 1 | 2018 | 130 | 0.030 |
Why?
| | Antibodies, Monoclonal | 1 | 2003 | 1359 | 0.030 |
Why?
| | Attention | 1 | 2020 | 434 | 0.030 |
Why?
| | Sex Characteristics | 1 | 2001 | 722 | 0.030 |
Why?
| | Pneumonia, Viral | 1 | 2020 | 361 | 0.030 |
Why?
| | Coronavirus Infections | 1 | 2020 | 355 | 0.030 |
Why?
| | Respiratory Tract Infections | 1 | 2019 | 372 | 0.030 |
Why?
| | DNA, Recombinant | 1 | 2014 | 46 | 0.030 |
Why?
| | Chromosome Deletion | 1 | 2013 | 104 | 0.030 |
Why?
| | Valine | 1 | 2013 | 78 | 0.030 |
Why?
| | Methionine | 1 | 2013 | 158 | 0.030 |
Why?
| | Transcriptome | 1 | 2018 | 871 | 0.020 |
Why?
| | Chi-Square Distribution | 1 | 2013 | 513 | 0.020 |
Why?
| | Sodium-Potassium-Chloride Symporters | 1 | 2011 | 9 | 0.020 |
Why?
| | New York | 1 | 2011 | 127 | 0.020 |
Why?
| | Symporters | 1 | 2011 | 54 | 0.020 |
Why?
| | Epigenomics | 1 | 2011 | 111 | 0.020 |
Why?
| | Glutamate Decarboxylase | 1 | 2011 | 165 | 0.020 |
Why?
| | Genetic Carrier Screening | 1 | 2010 | 25 | 0.020 |
Why?
| | Disks Large Homolog 4 Protein | 1 | 2010 | 16 | 0.020 |
Why?
| | Nitric Oxide Synthase Type I | 1 | 2010 | 27 | 0.020 |
Why?
| | Time | 1 | 2010 | 75 | 0.020 |
Why?
| | Cognition Disorders | 1 | 2014 | 496 | 0.020 |
Why?
| | Tremor | 1 | 2009 | 54 | 0.020 |
Why?
| | Movement Disorders | 1 | 2009 | 53 | 0.020 |
Why?
| | Neural Inhibition | 1 | 2009 | 151 | 0.020 |
Why?
| | Molecular Targeted Therapy | 1 | 2011 | 381 | 0.020 |
Why?
| | Siblings | 1 | 2009 | 220 | 0.020 |
Why?
| | Research | 1 | 2011 | 413 | 0.020 |
Why?
| | Control Groups | 1 | 2008 | 10 | 0.020 |
Why?
| | Cross-Sectional Studies | 1 | 2019 | 5032 | 0.020 |
Why?
| | Adaptor Proteins, Signal Transducing | 1 | 2010 | 395 | 0.020 |
Why?
| | Intracellular Signaling Peptides and Proteins | 1 | 2010 | 420 | 0.020 |
Why?
| | Artificial Intelligence | 1 | 2010 | 233 | 0.020 |
Why?
| | Immunoblotting | 1 | 2008 | 302 | 0.020 |
Why?
| | Cytoplasm | 1 | 2008 | 260 | 0.020 |
Why?
| | Pedigree | 1 | 2008 | 491 | 0.020 |
Why?
| | Anxiety Disorders | 1 | 2009 | 349 | 0.020 |
Why?
| | In Vitro Techniques | 1 | 2007 | 1061 | 0.020 |
Why?
| | Research Design | 1 | 2011 | 1038 | 0.020 |
Why?
| | Cell Nucleus | 1 | 2008 | 569 | 0.010 |
Why?
| | Models, Biological | 1 | 2011 | 1702 | 0.010 |
Why?
| | Cells, Cultured | 1 | 2011 | 4048 | 0.010 |
Why?
| | Glutamates | 1 | 2003 | 58 | 0.010 |
Why?
| | Mutation | 1 | 2014 | 3671 | 0.010 |
Why?
| | Algorithms | 1 | 2010 | 1626 | 0.010 |
Why?
| | Adaptor Proteins, Vesicular Transport | 1 | 2003 | 45 | 0.010 |
Why?
| | Serine Endopeptidases | 1 | 2003 | 113 | 0.010 |
Why?
| | Extracellular Matrix Proteins | 1 | 2003 | 144 | 0.010 |
Why?
| | Axons | 1 | 2003 | 181 | 0.010 |
Why?
| | Smoking | 1 | 2007 | 1501 | 0.010 |
Why?
| | Disease Progression | 1 | 2003 | 2603 | 0.010 |
Why?
| | Biomarkers | 1 | 2003 | 3874 | 0.010 |
Why?
|
|
Law's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|